Clinical Trial

The Effectiveness of Lymphatic Bypass Supermicrosurgery

Study acronym: ELYBS
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This study evaluate the effectiveness of lymphatic bypass supermicrosurgery (LBS) and axillary lymph node dissection (ALND) compare to ALND alone to prevent breast cancer treatment-related lymphedema (BCRL).
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2023-01-11; most recent amendment 2025-01-19.
Status change: Recruiting → Active, Not Recruiting 2025-01-19
Trial Details
NCT Number NCT05682885
Lead Sponsor Dharmais National Cancer Center Hospital
Conditions Breast Cancer Related Lymphedema, Lymphedema Arm
Enrollment 140 participants
Start Date 2022-10-06
Primary Completion 2027-10-31 (estimated)
Study Completion 2027-11-18 (estimated)
Updated on ClinicalTrials.gov 2025-01-22